Literature DB >> 11980254

Pharmacoepidemiology--an Irish perspective.

D Williams1, J Feely.   

Abstract

The Irish healthcare system is a mixture of free, state-supported and private medicine. The state-supported General Medical Services (GMS) scheme maintains a large prescription database, which has been used to conduct pharmacoepidemiological studies in Ireland. The dataset is anonymized thus maintaining patient and prescriber confidentiality. Three recent studies using this data are described, two of which outline the effect of regulatory advice and the media on prescribing patterns and one which describes the development of an index of prescribing quality which may be applied to prescription data. The GMS prescription database is presently being complemented by a database for some 0.7 million people who seek reimbursement for prescriptions from individuals or families in excess of 42 Pounds per month which together will have an important role for the continued development of pharmacoepidemiology in Ireland.

Entities:  

Mesh:

Year:  2001        PMID: 11980254     DOI: 10.1002/pds.640

Source DB:  PubMed          Journal:  Pharmacoepidemiol Drug Saf        ISSN: 1053-8569            Impact factor:   2.890


  5 in total

1.  Effect of clinical trial publicity on HRT prescribing in Ireland.

Authors:  C Usher; M Teeling; K Bennett; J Feely
Journal:  Eur J Clin Pharmacol       Date:  2006-01-24       Impact factor: 2.953

2.  Characterizing new users of NSAIDs before and after rofecoxib withdrawal.

Authors:  Cara Usher; Kathleen Bennett; Mary Teeling; John Feely
Journal:  Br J Clin Pharmacol       Date:  2006-10-19       Impact factor: 4.335

3.  Changes in prevalence of and prescribing for ischaemic heart disease in Ireland 1990-2002.

Authors:  K Bennett; H Johnson; P Dack; E Shelley; J Feely
Journal:  Ir J Med Sci       Date:  2005 Jul-Sep       Impact factor: 1.568

4.  Evidence for an age and gender bias in the secondary prevention of ischaemic heart disease in primary care.

Authors:  David Williams; Kathleen Bennett; John Feely
Journal:  Br J Clin Pharmacol       Date:  2003-06       Impact factor: 4.335

5.  Propranolol and survival from breast cancer: a pooled analysis of European breast cancer cohorts.

Authors:  Chris R Cardwell; Anton Pottegård; Evelien Vaes; Hans Garmo; Liam J Murray; Chris Brown; Pauline A J Vissers; Michael O'Rorke; Kala Visvanathan; Deirdre Cronin-Fenton; Harlinde De Schutter; Mats Lambe; Des G Powe; Myrthe P P van Herk-Sukel; Anna Gavin; Søren Friis; Linda Sharp; Kathleen Bennett
Journal:  Breast Cancer Res       Date:  2016-12-01       Impact factor: 6.466

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.